Who are Johnson & Johnson's investors?

Johnson & Johnson's investors include Aisling Capital, Atlas Venture, NaviMed Capital, Portland Seed Fund, SPRINGROCK VENTURES, The Column Group, venBio Partners.

Where is Johnson & Johnson headquartered?

Johnson & Johnson is headquartered in New Brunswick, US.

Johnson & Johnson

NYSE: JNJ

New Brunswick, US · Incorporated in New Jersey · 7 known investors

jnj.com ↗

Johnson & Johnson is a diversified healthcare company operating across 260 subsidiary companies with approximately 138,000 employees globally. The organization develops pharmaceuticals, medical devices, and healthcare solutions across therapeutic areas including cardiology, oncology, immunology, neuroscience, and orthopaedics, alongside digital health and surgical robotics technologies.

BiotechHealthtechMedical Devices

Founders & leadership

Joaquin Duatoin

Investors · 7

Aisling CapitalNew York

Atlas VentureCambridge · $500K – $1M

NaviMed CapitalRosslyn · $5M – $30M

Portland Seed FundPortland · $25K

SPRINGROCK VENTURESSeattle · $2M – $5M

The Column GroupSan Francisco · $30M

venBio PartnersSan Francisco

Founder mafia

The Johnson & Johnson mafia →

25 people who came through Johnson & Johnson went on to found or lead other companies.

Serge MesserlianPresident, OncologyFounded Creyon +1 Kim RodriguezDirector of SalesFounded BrainCheck +1 Sid ViswanathanGlobal Operations Leadership DevelopmentFounded Alchemy Health +1 Peter EmighFormulationsFounded Savoy Life Sebastian RualesCategory Management ManagerFounded Bia Arthur SuckowPostdocFounded DTx Pharma Gatanya ArnicCorporate Health AssociateFounded Centerforyouthwellness Katie SunnucksHealth Economics and Market Access Research AssistantFounded Vantage Biosciences Dirk ReynPrepulsid Team LeaderFounded Spectricity Tao FuVice President, Business Development, Head of Mergers and Acquisitions/Pharmaceuticals GroupFounded Attovia Therapeutics Lalo FloresVice President of R&DFounded Novira Therapeutics Jacopo LeonardiDirector of MarketingFounded Pheast Therapeutics

+ 13 more

Acquisitions · 5

Early investors' stakes continue via these deals

Conor Medsystems

Developer of drug-eluting stents for coronary artery disease; IPO'd in 2004 and acquired by J&J in 2007.

Covagen AG

Developed next-generation protein drugs for inflammatory diseases and cancer; acquired by J&J in 2014.

Ensure Medical

Developed a bio-erodable femoral closure device; acquired by Johnson & Johnson for up to $90M.

Neuravi

Developer of the EmboTrap stroke treatment device for removing clots from the brain; acquired by Johnson & Johnson.

Taris Bio

Originator of Inlexzo (gemcitabine intravesical system), an FDA-approved treatment for certain bladder cancers; acquired by Johnson & Johnson in 2019.

In the news

Johnson & Johnson Leads 9M Investment In Personal Genetics Startup 23andMetechcrunch.com · Jan 2011

Frequently asked questions

What does Johnson & Johnson do?: Johnson & Johnson is a diversified healthcare company operating across 260 subsidiary companies with approximately 138,000 employees globally. The organization develops pharmaceuticals, medical devices, and healthcare solutions across therapeutic areas including cardiology, oncology, immunology, neuroscience, and orthopaedics, alongside digital health and surgical robotics technologies.
Who are Johnson & Johnson's investors?: Johnson & Johnson's investors include Aisling Capital, Atlas Venture, NaviMed Capital, Portland Seed Fund, SPRINGROCK VENTURES, The Column Group, venBio Partners.
Where is Johnson & Johnson headquartered?: Johnson & Johnson is headquartered in New Brunswick, US.